OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors

NCT00471432 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

NETWORK

Sponsor class

Conditions

Bladder Cancer
Breast Cancer
Kidney Cancer
Lung Cancer
Ovarian Cancer
Prostate Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: custirsen sodium
DRUG: docetaxel
OTHER: pharmacological study

Sponsor

NCIC Clinical Trials Group